Anjali Pandey

Anjali Pandey is an executive leader with 25+ years of experience in CSO/SVP roles through all stages of discovery through launch. Anjali previously served as SVP of Medicinal Chemistry & Chemical Development at Portola Pharmaceuticals, where she managed discovery and CMC for Bevyxxa™ and Cerdulatinib. Most recently, Anjali held CSO/EVP positions at BridgeBio Pharma subsidiaries TheRas, Inc. and Ferro Therapeutics. Dr. Pandey has published 45+ scientific publications and is inventor on 60 issued U.S. patents. She holds an MS from the Indian Institute of Technology, a PhD from Southern Illinois University, and completed her postdoctoral fellowship at SRI International.